Alnylam Pharmaceuticals, Inc.

Report date
3/31/2026
Quarter
2026 Q1
Filed
5/13/2026
Shares
1,356,036
Value ($000)
448,671
Weight
0.4%
2019 Q4 - 2026 Q1 (11 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).